Adenovirus HER2-transduced autologous dendritic cell vaccine

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

adenovirus HER2-transduced autologous dendritic cell vaccine A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a replication-deficient adenovirus vector encoding HER-2 with potential antineoplastic activity. Upon administration, adenovirus HER2-transduced autologous dendritic cell vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against HER-2-positive tumor cells, which may result in tumor cell death and decreased tumor growth. HER-2, a tyrosine kinase receptor for epidermal growth factor (EGF) (also known as neu and ErbB2), is overexpressed by some breast, ovarian, and gastric cancers.

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article Adenovirus HER2-transduced autologous dendritic cell vaccine is a stub. If you are familiar with the topic Adenovirus HER2-transduced autologous dendritic cell vaccine, you can help us. Paid editors welcome!


 

Adenovirus HER2-transduced autologous dendritic cell vaccine is part of WikiMD's free ^articles!

^Adenovirus HER2-transduced autologous dendritic cell vaccine (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available